¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : ½ºÀ§½º ±×·£µå È£ÅÚ ÄÁº¥¼Ç ¼¾ÅÍ

±³À°ÁÖÁ¦ : 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺÎÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ¹Ú¹Î¿µ
¿¬¶ôó : 02-318-5416  

À̸ÞÀÏ : khrs10@k-hrs.org

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 100,000¿ø  

ºñ°í »çÀüµî·Ï ½Ã : Àü¹®ÀÇ(±³¼ö, °³¿øÀÇ, ºÀÁ÷ÀÇ) - 10¸¸¿ø / ÀüÀÓÀÇ - 7¸¸¿ø / Àü°øÀÇ, ±ºÀÇ°ü, °£È£»ç, ¹æ»ç¼±»ç, ÀÓ»óº´¸®»ç, ÀÇ·á±â±â ¹× Á¦¾àȸ»ç Á¾»çÀÚ - 5¸¸¿ø / ¿¬±¸¿ø - 3¸¸¿ø / Çлý, ¿Ü±¹ÀÎ(Physician, Scientist), 65¼¼ ÀÌ»ó Àü¹®ÀÇ(±³¼ö, °³¿øÀÇ, ºÀÁ÷ÀÇ) - µî·Ïºñ ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 08:45~09:05 Cryoballoon ablation for AF in Korea: complications and outcomes from a multicenter registry ¾çÇʼº(Â÷ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:05~09:25 Predictors of failure to maintain sinus rhythm after RF catheter ablation of AF ±è´ëÈÆ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:25~09:45 Catheter ablation of AF in patients with heart failure Ming-long Chen(The First Affiliated Hospital of Nanjing Medical University)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 09:45~10:05 Cryoballoon ablation for longstanding persistent AF ÀÌ»óÈñ(Æ÷Ç× ¼¼¸í±âµ¶º´¿ø)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:05~10:25 Initial experiences of PFA for AF in Singapore Pipin Kojodjojo(ASIAN HEART & VASCULAR CENTRE)

ÈÞ½Ä 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:25~10:30 Break ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:30~10:50 Oral anticoagulation for stroke prevention, warfarin to Factor XI inhibitor Á¤·¡¿µ(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 10:50~11:10 Symptom scales of AF currently in use, is it suitable? ÃÖÁøÈñ(¾ç»êºÎ»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:10~11:30 Can early rhythm control therapy prevent the AF progression? ÀÌ´ëÀÎ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:30~11:50 How to treat tachycardia induced CMP? Rhythm vs Rate (including AVN ablation) °ûÇýºó(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 11:50~12:10 Lifestyle and Risk factor modification for reduction of atrial fibrillation - recommendation for physical activity Wei-Chung Tsai (Kaohsiung Medical University)

½Ä»ç 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 12:10~13:20 Lunch ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 13:20~13:40 Unmet need for new energy source (complications of thermal ablation) ½ÉÀç¹Î(°í·ÁÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 13:40~14:00 Clinical data of PFA (catheter configuration / energy delivery method / successful PVI rate / recurrence rate / procedural time) Kyoung-Ryul Julian Chun(CCB Frankfurt)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:00~14:20 Ischemic stroke after PFA (thrombotic or air embolic / accidental LAA electrical isolation) ±è¹®Çö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:20~14:40 Collateral damage after PFA (phrenic nerve / coronary artery / esophagus) À̱¤³ë(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 14:40~15:00 My experience on pulse field ablation for atrial fibrillation Boris Schmidt(Cardiologisches Centrum Bethanien)

ÈÞ½Ä 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:00~15:05 Break ()

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:05~15:25 Ablation in ARVC Fa-Po Chung(Taipei Veterans General Hospital)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:25~15:45 Epicardial Ablation in Brugada Syndrome ¹Ú¿¹¹Î(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 15:45~16:05 Ablation for Papillary Muscle VT Á¶¹Î¼ö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 16:05~16:25 Ablation for ischemic VT Â÷¸íÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ÄÁº¥¼Ç¼¾ÅÍ 16:25~16:45 Ablation for LV summit VA Yenn-Jiang Lin(Taipei Veterans General Hospital)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÁ¤¸ÆÇÐȸ 2023 KHRS Autumn Scientific Session: AF Summit 2023(2ÀÏÂ÷) : 2023-12-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦3ȸ ´«¿°Áõ ¿µ»ó°¶·¯¸® : 2023-12-02
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÀÓ»óÅëÁõÇÐȸ ¿Â¶óÀÎ 2023³â ¸®ºäÄÚ½º : 2023-12-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 613 2018-07-28
145 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Cadaver Workshop : 2018-08-26 0 672 2018-07-28
144 ¼­¿ï °³¿ø 50Áֳ⠱â³ä Á¦ 9ȸ °­ºÏ»ï¼ºº´¿ø ´ç´¢Ç÷°ü¼¾ÅÍ ¿¬¼ö°­Á -´ç´¢º´ °ü¸® ¹× ÇÕº´Áõ ¿¹¹æÀ» À§ÇÑ 100³â ´ë°è : 2018-08-26 0 965 2018-07-28
143 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-26 0 654 2018-07-28
142 ¼­¿ï 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦21Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-08-26 0 360 2018-07-28
141 ¼­¿ï Á¦16Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 506 2018-07-28
140 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease (Day 2) : 2018-08-26 0 371 2018-07-28
139 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ ¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø À̺ñÀÎÈÄ°ú 50Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-08-26 0 503 2018-07-28
138 ¼­¿ï Á¦14ȸ ÀÓ»óÀÌ°úÇм¼¹Ì³ª(´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ&´ëÇÑÀÌÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-26 0 655 2018-07-28
137 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø Á¦4ȸ Áß¾Ó´ëÇб³ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-08-26 0 478 2018-07-28
136 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø 13th Yonsei Foot & Ankle Cadaveric Workshop : 2018-08-26 0 409 2018-07-28
135 °æ±â Á¦59ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¼¼¹Ì³ª : 2018-08-26 0 1,844 2018-07-28
134 ¼­¿ï Á¦8ȸ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â¼¾ÅÍ ½ÉÆ÷Áö¾ö(ÁÖÁ¦: ÈçÈ÷ ¸¸³ª°Ô µÇ´Â ¼Ò¾Æû¼Ò³â Áúȯ) : 2018-08-26 0 723 2018-07-28
133 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦9ȸ ¿¬¼¼ÀÇ´ë ¼Ò¾Æ°úÇб³½Ç, ¼Ò¾Æ¾Ë·¹¸£±âÈ£Èí±âÁúȯ ¿¬¼ö°­Á : 2018-08-26 0 395 2018-07-28
132 ¼­¿ï 2018 ´ëÇѼö¸éÇÐȸ ¿öÅ©¼¥ : 2018-08-26 0 482 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷